Litcius/Paper detail

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Mine Durusu Tanrıöver, Levent Doğanay, Murat Akova, Rahmet Güner, Alpay Azap, Sıla Akhan, Şükran Köse, Fatma Şebnem Erdinç, Halis Akalın, Ömer Fehmi Tabak, Hüsnü Pullukçu, Özgür Batum, Serap Şimşek Yavuz, Özge Turhan, Taner Yıldırmak, İftihar Köksal, Yeşim Taşova, Volkan Korten, Gürdal Yılmaz, Mustafa Kemal Çelen, Sedat Altın, İ̇lhami Çelik, Yaşar Bayındır, İlkay Karaoğlan, Aydın Yılmaz, Aykut Özkul, Hazal Gür, Serhat Ünal, Bircan Kayaaslan, İmran Hasanoğlu, A. Dalkiran, Ömer Aydos, Güle Çınar, İrem Akdemir Kalkan, Ahmet Çağkan İnkaya, Mehtap Aydın, Hatice Çakır, Jale Yıldız, Özenir Kocabıyık, Sonay Arslan, Bayram Nallı, Ömer Furkan Demir, Sarp Singil, Çigdem Ataman Hatipoğlu, Günay Tuncer Ertem, Sami Kınıklı, Uğur Önal, Bilgül Mete, Gözde Dalgan, Meltem Taşbakan, Tansu Yamazhan, Berna Kömürcüoğlu, Enver Yalnız, Aysun Benli, Çağla Keskin-Sarıtaş, Mustafa Gökhan Ertosun, Özlenen Özkan, Salih Emre, Seçil Arıca, Ferit Kuşçu, Aslıhan Candevir, Buket Ertürk Şengel, Fadime Ayvaz, Firdevs Aksoy, Çiğdem Mermutluoğlu, Yakup Demir, Gülşah Günlüoğlu, Seda Tural Önür, Ayşin Kılınç Toker, Esma Eren, Barış Otlu, Ayşe Özlem Mete, Kübra Koçak, Hale Ateş, İlkay Koca-Kalkan, Kurtuluş Aksu

2021The Lancet930 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePlaceboPopulationCohortInternal medicineRandomized controlled trialClinical trialVaccine trialAdverse effectInterim analysisVaccinationImmunologyPathologyEnvironmental healthAlternative medicineSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey | Litcius